Tyrosine kinase inhibitors (TKI) are employed to attack specific types of cancer cells. The downside to using TKs is that they can cause serious inflammation. A team of researchers has discovered the underlying mechanism that causes this inflammation.
Click here for original story, How TKI cancer drugs cause inflammatory side effects
Source: ScienceDaily